NCT05604040 is a NA clinical trial of Lifestyle Modifications in Hypertension, sponsored by The Cleveland Clinic.

Who is sponsoring NCT05604040?

NCT05604040 is sponsored by The Cleveland Clinic.

What drugs are being tested in NCT05604040?

Interventions in NCT05604040: Lifestyle Modifications.

What condition does NCT05604040 study?

NCT05604040 studies Hypertension.

Is NCT05604040 still recruiting?

NCT05604040 is currently completed. Last updated 25 November 2024.

Last reviewed 2024-11-25 · How we verify

NCT05604040

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Home Blood Pressure Monitoring to Improve Hypertension

Completed NA Last updated 25 November 2024

What this trial tests

NA trial testing Lifestyle Modifications in Hypertension in 33 participants. Completed in 16 June 2024.

Timeline

14 October 2022

Primary endpoint
16 June 2023

16 June 2024

Quick facts

Lead sponsor	The Cleveland Clinic
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	health services research
Enrollment	33
Start date	14 October 2022
Primary completion	16 June 2023
Estimated completion	16 June 2024
Sites	1 location across United States

Drugs / interventions tested

Lifestyle Modifications

Conditions studied

Hypertension — all drugs for Hypertension →

Sponsor

The Cleveland Clinic

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this single group pre-post-study is to test the possibility of self-monitoring with shared medical appointments program for lifestyle education in improving blood pressure (BP) of patients with uncontrolled hypertension. The main questions it aims to address is: 1. To assess if patients with uncontrolled hypertension and their physicians will be interested in trying a program that includes self-monitoring with 6-week support for lifestyle changes and coping skills to improve BP and hypertension control. 2. To assess if patients with uncontrolled hypertension can safely participate in a program that includes self-monitoring with 6-week support for lifestyle changes and coping skills to improve their BP and ability to self-manage hypertension Participants will: * Send self-reports of their home BPs, diet, physical activity and emotions * Attend 6-week education program of lifestyle changes and coping skills delivered by physicians, holistic psychotherapists and yoga therapists.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Self-Monitoring With Coping Skills and Lifestyle Education for Hypertension Control in Primary Care.
Patil SJ, Guo N, Udoh EO, Todorov I. · · 2024 · cited 1× · PMID 39437225 · DOI 10.1111/jch.14921
A Mixed Methods Evaluation of Ecological Momentary Assessments: The Impact of Self-Monitoring and Lifestyle Education in Patients With Uncontrolled Hypertension.
Patil SJ, Guo N, Todorov I, Gunzler D. · · 2025 · PMID 40503547 · DOI 10.7759/cureus.85734

Verify or expand the search:

Other trials of Lifestyle Modifications

Trials testing the same drug.

NCT03979677 — Effects of Lifestyle Modification on Vestibular Migraine · NA · completed
NCT03226054 — Determining Risk Factors for Successful PPI Weaning · NA · terminated

Other recruiting trials for Hypertension

Currently open trials in the same condition.

NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting

Other The Cleveland Clinic trials

Trials by the same sponsor.

NCT07218198 — Clinical Decision Support Tool for the Treatment of Uncontrolled Hypertension · NA · not yet recruiting
NCT07442747 — Neural Mechanisms of Aerobic Exercise Benefits in PD With DBS · NA · not yet recruiting
NCT07471464 — Centered Surgery - Preoperative Counseling and Patient Satisfaction · recruiting
NCT07073963 — Virtual Patient Groups for Sarcoidosis Associated Fatigue · NA · recruiting
NCT07363343 — Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05604040 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Cleveland Clinic
Last refreshed: 25 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05604040.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing